ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,3773
0,50%
Bitcoin
66.622,75
0,65%
Brent Oil
82,275
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Arch Therapeutics Inc (QB) (ARTH)

  7. Arch Therapeutics Inc (QB) (ARTH) Notícias

ARTH

Arch Therapeutics (QB) (ARTH)

Arch Therapeutics Inc (QB)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:ARTH
DataHoraFonteTítuloCódigoCompanhia
22/06/202317:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
23/05/202307:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
16/05/202307:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ARTHArch Therapeutics Inc (QB)
25/01/202317:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARTHArch Therapeutics Inc (QB)
23/01/202319:18Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHArch Therapeutics Inc (QB)
28/12/202218:52Edgar (US Regulatory)Annual Report (10-k)USOTC:ARTHArch Therapeutics Inc (QB)
31/08/202207:05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARTHArch Therapeutics Inc (QB)
30/08/202218:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:ARTHArch Therapeutics Inc (QB)
30/08/202207:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ARTHArch Therapeutics Inc (QB)
22/08/202207:04Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ARTHArch Therapeutics Inc (QB)
18/08/202207:03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ARTHArch Therapeutics Inc (QB)
17/08/202217:11Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ARTHArch Therapeutics Inc (QB)
15/08/202217:24Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
08/07/202218:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
22/03/202206:14TipRanksDawson James Remains a Buy on Arch Therapeutics (ARTH)USOTC:ARTHArch Therapeutics Inc (QB)
04/01/202218:18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ARTHArch Therapeutics Inc (QB)
28/12/202118:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:ARTHArch Therapeutics Inc (QB)
22/12/202118:08Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ARTHArch Therapeutics Inc (QB)
25/02/202114:27Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:ARTHArch Therapeutics Inc (QB)
17/10/201918:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:ARTHArch Therapeutics Inc (QB)
20/07/201814:15Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ARTHArch Therapeutics Inc (QB)
17/11/201616:35Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:ARTHArch Therapeutics Inc (QB)
31/10/201619:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:ARTHArch Therapeutics Inc (QB)
16/07/201609:00InvestorsHub NewsWireInsider Financial Publishes New Research On Three Promising BiotechsUSOTC:ARTHArch Therapeutics Inc (QB)
14/07/201609:33InvestorsHub NewsWireOne Step Vending Corp. KOSK – 230% Growth and Over 150,000 Units SuppliedUSOTC:ARTHArch Therapeutics Inc (QB)
14/10/201507:03Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ARTHArch Therapeutics Inc (QB)
16/06/201409:15MarketwiredArch Therapeutics Co-Founder Rutledge Ellis-Behnke to Speak at European Summit for Clinical Nanomedicine & Targeted Medicine ...USOTC:ARTHArch Therapeutics Inc (QB)
28/05/201410:00MarketwiredArch Therapeutics Inc. to Present at the LD MICRO Invitational 2014 on June 4thUSOTC:ARTHArch Therapeutics Inc (QB)
27/05/201410:00MarketwiredArch Therapeutics Inc. to Present at the Third Annual Marcum MicroCap ConferenceUSOTC:ARTHArch Therapeutics Inc (QB)
01/04/201409:00MarketwiredArch Therapeutics Appoints Chirag Shah, PhD as Vice President of R&D Engineering & Quality Systems & Peter LaCrosse as Chief ...USOTC:ARTHArch Therapeutics Inc (QB)
 Apresentando as notícias mais relevantes sobre:USOTC:ARTH

Seu Histórico Recente

BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
IBOV
Índice Bovespa
BOV
CMIN3
CSN Mineracao S.A ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados